A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders
- PMID: 33740483
- PMCID: PMC7927594
- DOI: 10.1016/j.psychres.2021.113856
A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders
Abstract
Several observational studies investigated the relationship between pre-diagnosis with mental disorders and COVID-19 outcomes. Thus, we have decided to conduct this meta-analysis to explore this relationship. We complied to the PRISMA guidelines in conducting this meta-analysis. PubMed, ScienceDirect, Google Scholar and medRxiv were searched until the 15th of February, 2021. We used the Random effect model in Meta XL, version 5.3 to pool the included studies. Statistical heterogeneity was assessed using Cochran's Q heterogeneity test and I². This meta-analysis included 634,338 COVID-19 patients from 16 studies. Our findings revealed that pre-diagnosis with mental disorders increased the risk of COVID-19 mortality and severity. This increase in the risk of COVID-19 mortality and severity remained significant in the model that only included the studies that adjusted for confounding variables. Furthermore, higher mortality was noticed in the included studies among schizophrenia, schizotypal and delusional disorders patients compared to mood disorders patients. In this meta-analysis we provided two models which both reported a significant increase in the risk of COVID-19 severity and mortality among patients with mental disorders, and with the upcoming COVID-19 vaccines, we recommend to give this category the priority in the vaccination campaigns along with medical health providers and elderly.
Keywords: Human; Meta-Analysis; Pandemics; Psychiatric diseases; SARS-COV-2; Systematic Reviews.
Copyright © 2021. Published by Elsevier B.V.
Conflict of interest statement
Declarations of interest: none.
Figures







Similar articles
-
Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review.BMC Psychiatry. 2023 Mar 20;23(1):181. doi: 10.1186/s12888-023-04641-y. BMC Psychiatry. 2023. PMID: 36941591 Free PMC article.
-
Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.Lancet Psychiatry. 2021 Sep;8(9):797-812. doi: 10.1016/S2215-0366(21)00232-7. Epub 2021 Jul 17. Lancet Psychiatry. 2021. PMID: 34274033 Free PMC article.
-
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. Lancet Psychiatry. 2020. PMID: 32437679 Free PMC article.
-
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis.JAMA Psychiatry. 2021 Nov 1;78(11):1208-1217. doi: 10.1001/jamapsychiatry.2021.2274. JAMA Psychiatry. 2021. PMID: 34313711 Free PMC article.
-
Proton Pump Inhibitors: Current Use and the Risk of Coronavirus Infectious Disease 2019 Development and its Related Mortality. Meta-analysis.Arch Med Res. 2021 Aug;52(6):656-659. doi: 10.1016/j.arcmed.2021.03.004. Epub 2021 Mar 26. Arch Med Res. 2021. PMID: 33814207 Free PMC article.
Cited by
-
Severe COVID-19 increases the risk of schizophrenia.Psychiatry Res. 2022 Nov;317:114809. doi: 10.1016/j.psychres.2022.114809. Epub 2022 Aug 24. Psychiatry Res. 2022. PMID: 36037742 Free PMC article.
-
The risk factors and predictive modeling of mortality in patients with mental disorders combined with severe pneumonia.Front Psychiatry. 2024 Jan 11;14:1300740. doi: 10.3389/fpsyt.2023.1300740. eCollection 2023. Front Psychiatry. 2024. PMID: 38274425 Free PMC article.
-
A Patient With Schizophrenia in Remission Relapses Following COVID-19: A Case Report.Cureus. 2022 Oct 2;14(10):e29845. doi: 10.7759/cureus.29845. eCollection 2022 Oct. Cureus. 2022. PMID: 36348867 Free PMC article.
-
Association between mental disorders and COVID-19 outcomes among inpatients in France: A retrospective nationwide population-based study.J Psychiatr Res. 2022 Nov;155:194-201. doi: 10.1016/j.jpsychires.2022.08.019. Epub 2022 Aug 20. J Psychiatr Res. 2022. PMID: 36063611 Free PMC article.
-
Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France.Biol Psychiatry Glob Open Sci. 2023 Jan;3(1):56-67. doi: 10.1016/j.bpsgos.2021.12.007. Epub 2022 Jan 4. Biol Psychiatry Glob Open Sci. 2023. PMID: 35013734 Free PMC article.
References
-
- Bauer M.E., Teixeira A.L. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci. 2019;1437(1):57–67. - PubMed
-
- Bauer, M.E., Teixeira, A.L., 2019b. Inflammation in psychiatric disorders: what comes first? 1437 (1), 57-67. - PubMed
-
- Cavallaro M., Moiz H., Keeling M.J., McCarthy N.D. 2020. Contrasting factors associated with COVID-19-related ICU and death outcomes: interpretable multivariable analyses of the UK CHESS dataset. 2020.2012.2003.20242941.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous